surmount-1 trial tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Discussing Promising New Findings Easy Touch Quantity:1 Bottle (30 Day Supply)

surmount-1 trial tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Discussing Promising New Findings Easy Touch Quantity:1 Bottle (30 Day Supply)

Discussing Promising New Findings on GLP-1 Use in Psoriasis Management, With Neal Bhatia, MD

Avoid placing your medication directly on ice packs to prevent freezing

Easy Touch

Quantity:1 Bottle (30 Day Supply)

Regular check-ins assess progress and tolerability, ensuring your treatment plan supports your personal weight-loss goals